HRTX
Heron Therapeutics Inc
Halal Rating :
Last Price
$1.63
Last updated:
Market Cap
-
7D Change
5.84%
1 Year Change
-30.34%
Company Overview
Industries
Exchange
Next Earnings Date
Heron Therapeutics Inc is a biotechnology company focused on developing and commercializing solutions to improve the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs. The company's advanced science, patented technologies, and innovative approach to drug development allow it to create and commercialize pharmaceutical products that target prescription medical needs in pain management and cancer supportive care.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $32.81m | $37.27m | - | - | 0.00% | 0.00% |
| June 30, 2024 | $36.02m | $42.47m | - | - | 0.00% | 0.00% |
| March 31, 2024 | $34.67m | $39.47m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate Heron Therapeutics Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.